Product proliferation and consumer demand create challenges for retailers at the shelf where room must be made for new Rx-to-OTC items
Rx-to-OTC switches in the stomach care category bring additional sales, but they can sometimes be hard for food retailers to digest, given restricted shelf space. A potential new entry to watch is the heartburn treatment drug Zegerid, from Shering-Plough Corp., Kenilworth, N.J. The drug maker applied this year to the U.S. Food and Drug Administration for a new drug application for an OTC low-dose version. Perrigo, Allegan, Mich., began shipping Omeprazole, a store-brand heartburn remedy ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?